Reference number
ISO 10993-5:2009(E)
© ISO 2009
INTERNATIONAL
STANDARD
ISO
10993-5
Third edition
2009-06-01
Biological evaluation of medical
devices —
Part 5:
Tests for in vitro cytotoxicity
Évaluation biologique des dispositifs médicaux —
Partie 5: Essais concernant la cytotoxicité in vitro
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
--``,,,,,,,,,,``,,````,,,````,,-`-`,,`,,`,`,,`---
ISO 10993-5:2009(E)
PDF disclaimer
This PDF file may contain embedded typefaces. In accordance with Adobe's licensing policy, this file may be printed or viewed but
shall not be edited unless the typefaces which are embedded are licensed to and installed on the computer performing the editing. In
downloading this file, parties accept therein the responsibility of not infringing Adobe's licensing policy. The ISO Central Secretariat
accepts no liability in this area.
Adobe is a trademark of Adobe Systems Incorporated.
Details of the software products used to create this PDF file can be found in the General Info relative to the file; the PDF-creation
parameters were optimized for printing. Every care has been taken to ensure that the file is suitable for use by ISO member bodies. In
the unlikely event that a problem relating to it is found, please inform the Central Secretariat at the address given below.
COPYRIGHT PROTECTED DOCUMENT
© ISO 2009
All rights reserved. Unless otherwise specified, no part of this publication may be reproduced or utilized in any form or by any means,
electronic or mechanical, including photocopying and microfilm, without permission in writing from either ISO at the address below or
ISO's member body in the country of the requester.
ISO copyright office
Case postale 56 • CH-1211 Geneva 20
Tel. + 41 22 749 01 11
Fax + 41 22 749 09 47
E-mail copyright@iso.org
Web www.iso.org
Published in Switzerland
ii © ISO 2009 – All rights reserved
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
-
-
`
`
,
,
,
,
,
,
,
,
,
,
`
`
,
,
`
`
`
`
,
,
,
`
`
`
`
,
,
-
`
-
`
,
,
`
,
,
`
,
`
,
,
`
-
-
-
ISO 10993-5:2009(E)
© ISO 2009 – All rights reserved iii
Contents Page
Foreword............................................................................................................................................................ iv
Introduction ....................................................................................................................................................... vi
1 Scope ..................................................................................................................................................... 1
2 Normative references ........................................................................................................................... 1
3 Terms and definitions........................................................................................................................... 1
4 Sample and control preparation.......................................................................................................... 2
4.1 General................................................................................................................................................... 2
4.2 Preparation of liquid extracts of material........................................................................................... 3
4.3 Preparation of material for direct-contact tests ................................................................................ 4
4.4 Preparation of controls ........................................................................................................................ 5
5 Cell lines ................................................................................................................................................ 5
6 Culture medium..................................................................................................................................... 5
7 Preparation of cell stock culture ......................................................................................................... 6
8 Test procedures .................................................................................................................................... 6
8.1 Number of replicates ............................................................................................................................ 6
8.2 Test on extracts .................................................................................................................................... 6
8.3 Test by direct contact........................................................................................................................... 7
8.4 Test by indirect contact........................................................................................................................ 7
8.5 Determination of cytotoxicity .............................................................................................................. 9
9 Test report ........................................................................................................................................... 10
10 Assessment of results........................................................................................................................ 11
Annex A (informative) Neutral red uptake (NRU) cytotoxicity test.............................................................. 12
Annex B (informative) Colony formation cytotoxicity test........................................................................... 19
Annex C (informative) MTT cytotoxicity test ................................................................................................. 24
Annex D (informative) XTT cytotoxicity test .................................................................................................. 29
Bibliography ..................................................................................................................................................... 34
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
--``,,,,,,,,,,``,,````,,,````,,-`-`,,`,,`,`,,`---
ISO 10993-5:2009(E)
iv © ISO 2009 – All rights reserved
Foreword
ISO (the International Organization for Standardization) is a worldwide federation of national standards bodies
(ISO member bodies). The work of preparing International Standards is normally carried out through ISO
technical committees. Each member body interested in a subject for which a technical committee has been
established has the right to be represented on that committee. International organizations, governmental and
non-governmental, in liaison with ISO, also take part in the work. ISO collaborates closely with the
International Electrotechnical Commission (IEC) on all matters of electrotechnical standardization.
International Standards are drafted in accordance with the rules given in the ISO/IEC Directives, Part 2.
The main task of technical committees is to prepare International Standards. Draft International Standards
adopted by the technical committees are circulated to the member bodies for voting. Publication as an
International Standard requires approval by at least 75 % of the member bodies casting a vote.
Attention is drawn to the possibility that some of the elements of this document may be the subject of patent
rights. ISO shall not be held responsible for identifying any or all such patent rights.
ISO 10993-5 was prepared by Technical Committee ISO/TC 194, Biological evaluation of medical devices.
This third edition cancels and replaces the second edition (ISO 10993-5:1999) which has been technically
revised.
ISO 10993 consists of the following parts, under the general title Biological evaluation of medical devices:
⎯ Part 1: Evaluation and testing within a risk management process
⎯ Part 2: Animal welfare requirements
⎯ Part 3: Tests for genotoxicity, carcinogenicity and reproductive toxicity
⎯ Part 4: Selection of tests for interactions with blood
⎯ Part 5: Tests for in vitro cytotoxicity
⎯ Part 6: Tests for local effects after implantation
⎯ Part 7: Ethylene oxide sterilization residuals
⎯ Part 9: Framework for identification and quantification of potential degradation products
⎯ Part 10: Tests for irritation and skin sensitization
⎯ Part 11: Tests for systemic toxicity
⎯ Part 12: Sample preparation and reference materials
⎯ Part 13: Identification and quantification of degradation products from polymeric medical devices
⎯ Part 14: Identification and quantification of degradation products from ceramics
⎯ Part 15: Identification and quantification of degradation products from metals and alloys
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
--``,,,,,,,,,,``,,````,,,````,,-`-`,,`,,`,`,,`---
ISO 10993-5:2009(E)
© ISO 2009 – All rights reserved v
⎯ Part 16: Toxicokinetic study design for degradation products and leachables
⎯ Part 17: Establishment of allowable limits for leachable substances
⎯ Part 18: Chemical characterization of materials
⎯ Part 19: Physico-chemical, morphological and topographical characterization of materials [Technical
Specification]
⎯ Part 20: Principles and methods for immunotoxicology testing of medical devices [Technical Specification]
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
-
-
`
`
,
,
,
,
,
,
,
,
,
,
`
`
,
,
`
`
`
`
,
,
,
`
`
`
`
,
,
-
`
-
`
,
,
`
,
,
`
,
`
,
,
`
-
-
-
ISO 10993-5:2009(E)
vi © ISO 2009 – All rights reserved
Introduction
Due to the general applicability of in vitro cytotoxicity tests and their widespread use in evaluating a large
range of devices and materials, it is the purpose of this part of ISO 10993, rather than to specify a single test,
to define a scheme for testing which requires decisions to be made in a series of steps. This should lead to
the selection of the most appropriate test.
Three categories of test are listed: extract test, direct contact test, indirect contact test.
The choice of one or more of these categories depends upon the nature of the sample to be evaluated, the
potential site of use and the nature of the use.
This choice then determines the details of the preparation of the samples to be tested, the preparation of the
cultured cells, and the way in which the cells are exposed to the samples or their extracts.
At the end of the exposure time, the evaluation of the presence and extent of the cytotoxic effect is undertaken.
It is the intention of this part of ISO 10993 to leave open the choice of type of evaluation. Such a strategy
makes available a battery of tests, which reflects the approach of many groups that advocate in vitro biological
tests.
The numerous methods used and endpoints measured in cytotoxicity determination can be grouped into the
following categories of evaluation:
⎯ assessments of cell damage by morphological means;
⎯ measurements of cell damage;
⎯ measurements of cell growth;
⎯ measurements of specific aspects of cellular metabolism.
There are several means of producing results in each of these four categories. The investigator should be
aware of the test categories and into which category a particular technique fits, in order that comparisons be
able to be made with other results on similar devices or materials both at the intra- and interlaboratory level.
Examples of quantitative test protocols are given in annexes. Guidance for the interpretation of the results is
given in this part of ISO 10993.
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
--``,,,,,,,,,,``,,````,,,````,,-`-`,,`,,`,`,,`---
INTERNATIONAL STANDARD ISO 10993-5:2009(E)
© ISO 2009 – All rights reserved 1
Biological evaluation of medical devices —
Part 5:
Tests for in vitro cytotoxicity
1 Scope
This part of ISO 10993 describes test methods to assess the in vitro cytotoxicity of medical devices.
These methods specify the incubation of cultured cells in contact with a device and/or extracts of a device
either directly or through diffusion.
These methods are designed to determine the biological response of mammalian cells in vitro using
appropriate biological parameters.
2 Normative references
The following referenced documents are indispensable for the application of this document. For dated
references, only the edition cited applies. For undated references, the latest edition of the referenced
document (including any amendments) applies.
ISO 10993-1, Biological evaluation of medical devices — Part 1: Evaluation and testing within a risk
management system
ISO 10993-12, Biological evaluation of medical devices — Part 12: Sample preparation and reference
materials
3 Terms and definitions
For the purposes of this document, the terms and definitions given in ISO 10993-1 and the following apply.
3.1
culture vessels
vessels appropriate for cell culture including glass petri dishes, plastic culture flasks or plastic multiwells and
microtitre plates
NOTE These can be used interchangeably in these methods provided that they meet the requirements of tissue
culture grade and are suitable for use with mammalian cells.
3.2
positive control material
material which, when tested in accordance with this part of ISO 10993, provides a reproducible cytotoxic
response
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
-
-
`
`
,
,
,
,
,
,
,
,
,
,
`
`
,
,
`
`
`
`
,
,
,
`
`
`
`
,
,
-
`
-
`
,
,
`
,
,
`
,
`
,
,
`
-
-
-
ISO 10993-5:2009(E)
2 © ISO 2009 – All rights reserved
NOTE The purpose of the positive control is to demonstrate an appropriate test system response. For example, an
organotin-stabilized polyurethane1) has been used as positive control for solid materials and extracts. Dilutions of phenol,
for example, have been used as a positive control for extracts. In addition to a material, pure chemicals can also be used
to demonstrate the performance of the test system.
3.3
blank
extraction vehicle not containing the test sample, retained in a vessel identical to that which holds the test
sample and subjected to conditions identical to those to which the test sample is subjected during its
extraction
NOTE The purpose of the blank is to evaluate the possible confounding effects due to the extraction vessel, vehicle
and extraction process.
3.4
negative control material
material which, when tested in accordance with this part of ISO 10993, does not produce a cytotoxic response
NOTE The purpose of the negative control is to demonstrate background response of the cells. For example,
high-density polyethylene2) for synthetic polymers, and aluminium oxide ceramic rods for dental material have been used
as negative controls.
3.5
test sample
material, device, device portion, component, extract or portion thereof that is subjected to biological or
chemical testing or evaluation
3.6
subconfluency
approximately 80 % confluency, i.e. the end of the logarithmic phase of growth
4 Sample and control preparation
4.1 General
The test shall be performed on
a) an extract of the test sample
and/or
b) the test sample itself.
Sample preparation shall be in accordance with ISO 10993-12.
Negative and positive controls shall be included in each assay.
1) The ZDEC and ZDBC polyurethanes are available from the Food and Drug Safety Center, Hatano Research Institute,
Ochiai 729-5, Hadanoshi, Kanagawa 257, Japan.
2) High-density polyethylene can be obtained from the U.S. Pharmacopeia (Rockville, MD, USA) and from the Food and
Drug Safety Center, Hatano Research Institute (Ochiai 729-5, Hadanoshi, Kanagawa 257, Japan).
The information given in 1) and 2) is for the convenience of the user of this part of ISO 10993 and does not constitute an
endorsement by ISO of these products. Equivalent products may be used if they can be shown to lead to the same results.
Copyright International Organization for Standardization
Provided by IHS under license with ISO Licensee=Istanbul Teknik Universtesi/5956919001, User=Jicheng, Piao
Not for Resale, 06/11/2009 16:45:28 MDTNo reproduction or networking permitted without license from IHS
--``,,,,,,,,,,``,,````,,,````,,-`-`,,`,,`,`,,`---
ISO 10993-5:2009(E)
© ISO 2009 – All rights reserved 3
4.2 Preparation of liquid extracts of material
4.2.1 Principles of extraction
Extracting conditions should attempt to simulate or exaggerate the clinical use conditions so as to determine
the potential toxicological hazard without causing significant changes in the test sample, such as fusion,
melting or any alteration of the chemical structure, unless this is expected during clinical application. Due to
the nature of certain materials (e.g. biodegradable materials), alteration of the chemical structure can occur
during the extraction procedure.
NOTE The concentration of any endogenous or extraneous substances in the extract, and hence the amount
exposed to the test cells, depends on the interfacial area, the extraction volume, pH, chemical solubility, diffusion rate,
osmolarity, agitation, temperature, time and other factors.
For devices that involve mixing two or more components in the patient to arrive at the final device (for example
bone cement), the final device should not be washed prior to extraction. Washing the test sample can reduce
or remove residuals present on the device. If the test sample is to be used in a sterile environment, a sterilized
test sample should be used to extract chemical constituents.
4.2.2 Extraction vehicle
The choice of the extraction vehicle(s) taking into account the chemical characteristics of the test sample shall
be justified and documented. For mammalian cell assays one or more of the following vehicles shall be used:
a) culture medium with serum;
b) physiological saline solution;
c) other suitable vehicle.
The choice of vehicle should reflect the aim of the extraction. Consideration shall be given to the use of both a
polar and a non-polar vehicle. Culture medium with serum is the preferred extraction vehicle. The use of
culture medium with serum is preferred for extraction because of its ability to support cellular growth as well as
extract both polar and non-polar substances. In addition to
本文档为【ISO 10993-5:2009(E)】,请使用软件OFFICE或WPS软件打开。作品中的文字与图均可以修改和编辑,
图片更改请在作品中右键图片并更换,文字修改请直接点击文字进行修改,也可以新增和删除文档中的内容。
该文档来自用户分享,如有侵权行为请发邮件ishare@vip.sina.com联系网站客服,我们会及时删除。
[版权声明] 本站所有资料为用户分享产生,若发现您的权利被侵害,请联系客服邮件isharekefu@iask.cn,我们尽快处理。
本作品所展示的图片、画像、字体、音乐的版权可能需版权方额外授权,请谨慎使用。
网站提供的党政主题相关内容(国旗、国徽、党徽..)目的在于配合国家政策宣传,仅限个人学习分享使用,禁止用于任何广告和商用目的。